Pig-to-human tissue transplants 'imminent'
Trials could begin in the US within two years – but British expert warns that safety fears remain
Jeremy Laurance is a writer on health issues. He is former health editor of The Independent and the i and has covered the specialism for more than 20 years. He thinks the harm medicine does is under-appreciated, the harm it prevents over-rated, and that cycling works better than most drugs. He was named Specialist Journalist of the Year in the 2011 British Press Awards.
Friday 21 October 2011
The world is on the cusp of a medical revolution which will see transplants of tissue from genetically engineered pigs to treat a range of human diseases, US scientists say today.
Click HERE to view graphic (103k jpg)
Human trials could begin within two to three years of tissue taken from specially bred pigs to help the millions of sufferers from diabetes, brain diseases and blindness.
But a British expert challenged their findings saying the safety issues were still "unresolved". The fear is that a retrovirus could jump from pigs to humans and trigger a new pandemic – HIV is thought to have started from a cross-species infection.
In a review of xenotransplantation – using animal tissue and organs to replace human ones – experts from the Thomas Starzl Transplantation Institute at the University of Pittsburgh say the technology has made "great strides".
During the mid-1990s, Imutran, a small biotechnology company in Cambridge, became the first in the world to transplant pigs' hearts into monkeys, demonstrating that cross-species transplantation was possible. However, immune system rejection problems proved more difficult than expected and safety fears dampened enthusiasm.
A decade on, attention has focused on the transplant of cells and tissues rather than organs – pancreatic islets for diabetics, brain cells for Parkinson's disease and corneas for the blind.
Problems remain, including loss of transplanted cells, blood clots and other rejection problems. New, genetically modified pigs will shortly become available which could overcome these issues and make human trials of transplanted tissue "imminent".
The US scientists discount safety fears saying retroviruses "do not pose a substantial risk".
That was challenged by Robin Weiss, professor of virology at University College, London, and an expert on retroviruses. He said yesterday: "I don't think the risk issues have been resolved. That doesn't mean clinical trials shouldn't go ahead but there would need to be very close monitoring of patients to ensure they were not picking something up from pigs."
Life & Style blogs
Alexander McQueen at auction: What makes a really great piece of fashion?
A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
No female ejaculation, please, we’re British: a history of porn and censorship
Stressed nurses are 'forced to choose between health of patients and their own'
Pornhub: Kim Kardashian's sex tape is the most-watched porn video of all-time
- 2 Harry Potter fans can apply to the Hogwarts-inspired College of Wizardry
- 3 Jessica Chambers: 19-year-old woman 'doused with lighter fluid and burned alive' in the US
- 4 Russell Brand calls Nigel Farage 'poundshop Enoch Powell' in BBC Question Time debate
- 5 Orange Wednesdays are no more
£65000 - £80000 per annum: Recruitment Genius: Finance Director required to jo...
£15000 - £25000 per annum: Recruitment Genius: This is a unique opportunity fo...
£50000 per annum + 26 days holiday,pension: Ashdown Group: A highly successful...
£27000 per annum + pension + holidays: The Jenrick Group: A Quality Technician...